[LETTER TO THE JOURNAL] Engineering small-molecule analogues of altiratinib via CREB-regulated transcription co-activator 3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases
- Clin. Transl. Med., Mar 2024, 14 (3) e1625 | https://doi.org/10.1002/ctm2.1625